Eli Lilly's (LLY) CDO says the Co. plans to sustain its aggressive dealmaking pace in 2026, Axios reports

Eli Lilly's commitment to maintain an aggressive dealmaking strategy signals a strong growth outlook and optimism in its pipeline.

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

US and Iran are not as far apart as they seem, and that the first part of any potential agreement will focus on opening the Strait of Hormuz without restrictions or fees, CNN reports, citing sources

Korea (Republic of) Business Confidence (Apr) 74 (Prev. 71)

Eli Lilly's (LLY) CDO says the Co. plans to sustain its aggressive dealmaking pace in 2026, Axios reports

Nucor (NUE) Q1 2026 (USD): Adj. EPS 3.23 (exp. 2.82), Revenue 9.50bln (exp. 8.88bln), EBITDA 1.51bln (exp. 1.33bln)

Eni (ENI IM)-RepsoI (REP SM) joint venture seeking to raise production at Venezuela’s Cardon IV gas field to 645mln cubic feet per day

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This could influence investor sentiment positively, not just for LLY but also for its peers in the pharmaceuticals sector, possibly leading to increased valuations and activity within the biotech and life sciences space.

Related headlines

The whole workspace, free to try.

Try it free